TITAN PHARMACEUTICALS INC 4
4 · TITAN PHARMACEUTICALS INC · Filed Mar 18, 2015
Insider Transaction Report
Form 4
TITAN PHARMACEUTICALS INCTTNP.OB
MACFARLANE M DAVID
Director
Transactions
- Award
Option to Purchase Common Stock
2015-03-16+25,000→ 25,000 totalExercise: $0.60From: 2015-03-16Exp: 2025-03-16→ Common Stock (25,000 underlying)